Home Biotech Weekly: Reviewing The
 

Keywords :   


Biotech Weekly: Reviewing The

2015-09-01 17:58:35| Biotech - Topix.net

The recent huge gains seen by holders of Aquinox Pharmaceuticals , Celsus Therapeutics , and Recro Pharma illustrate the potential of the Of the 35 names on the screen, I highlight Roka Biosciences, Nexvet Biopharma, OXiGENE, MEI Pharma, Biota Pharmaceuticals, Celladon, and Venaxis as names I like. I highlight Affymax, Tikro Technologies, Cadus Corporation, and Natural Alternatives International as potential investment opportunities, but cases where I need to do more due diligence.

Tags: weekly reviewing biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09Atlantic Tropical Weather Outlook
28.09Eastern North Pacific Tropical Weather Outlook
27.09Washington Corner | September 2024
27.09Hurricane Isaac Graphics
27.09Remnants of John Graphics
27.09Remnants of John Forecast Discussion Number 20
27.09Remnants of John Wind Speed Probabilities Number 20
27.09Remnants of John Public Advisory Number 20
More »